Market Overview

I think you’ll love what you hear,
what you’ll see and the opportunities
that will be set before you.
- Jon Najarian

7 Takeaways From Agilent's 10Q

7 Takeaways From Agilent's 10Q

Agilent Technologies Inc (NYSE: A) filed its FY2Q16 Form 10-Q on June 7, 2016. Barclays’ Jack Meehan maintained an Equal-Weight rating for the company, with a price target of $45. Following a review of the 10-Q filing, the analyst enumerated the following observations:

  • As of April 30, 2016, Agilent had 325,521,700 shares of common stock outstanding, representing a 0.1 percent decline with the FY1Q16 weighted average basic share count and a 2.3 percent y/y decline.
  • During the quarter, the company bought back about 2.6 million shares for a total of $94 million.
  • Related Link: Agilent's Guidance "Still Feels Conservative" To Wells Fargo

  • Agilent paid a quarterly dividend of $0.115 per share in FY1Q16 and FY2Q16, up from $0.10 in 2015.
  • The company provided details of its investment in Lasergen.
  • Agilent provided an update on its debt obligations.
  • The company disclosed six recent accounting pronouncements.
  • The filing was certified by CEO Mike McMullen and CFO Didier Hirsch as of June 6, 2016.
  • Latest Ratings for A

    May 2019MaintainsBuy
    May 2019MaintainsBuy
    May 2019MaintainsOverweight

    View More Analyst Ratings for A
    View the Latest Analyst Ratings

    Posted-In: Barclays Jack MeehanAnalyst Color Reiteration Analyst Ratings Best of Benzinga


    Related Articles (A)

    View Comments and Join the Discussion!

    Latest Ratings

    View the Latest Analytics Ratings
    Don't Miss Any Updates!
    News Directly in Your Inbox
    Subscribe to:
    Benzinga Trading Daily
    Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
    Market in 5 Minutes
    Everything you need to know about the market - quick & easy.
    Daily Analyst Rating
    A summary of each day’s top rating changes from sell-side analysts on the street.
    Thank You

    Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at

    Could Anadarko's Debt Be The Reason No M&A Rumors Have Come To Fruition?

    Micron Technology Expects Delay In Closing Of Inotera Acquisition